Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for methamphetamine addiction
ACTRN12616001614482Phase 2Recruiting
- Sponsor
- Linear Clinical Research
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Baclofen with Placebo (2 arms). Primary endpoint: Mesolimbic dopaminergic system activation on fMRI. Started Jan 2018; status: recruiting.
02
Drugs
baclofen
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on ACTRN12616001614482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001614482.